Immunobiological effects of tocilizumab across respiratory subphenotypes in COVID-19 ARDS by Emma Rademaker, Daan F. L. Filippini, Jelle L. G. Haitsma Mulier, Marleen A. Slim, Rombout B. E. van Amstel, Sivasubramanium V. Bhavani, Nicole P. Juffermans, Harm-Jan S. de Grooth, Lennie P. G. Derde, Olaf L. Cremer, Lieuwe D. J. Bos, Amsterdam U. M. C. COVID-19 Biobank Study Group

Get full text

Longitudinal Respiratory Subphenotypes and Differences in Response to Positive End-Expiratory Pressure and Fio2 Ventilation Strategy in COVID-19 ARDSTake-Home Points by Robin L. Goossen, MD, Daan F.L. Filippini, MD, Relin van Vliet, MD, Laura A. Buiteman-Kruizinga, RN, PhD, Markus W. Hollmann, MD, PhD, Sheila N. Myatra, MD, Ary Serpa Neto, MD, PhD, Peter E. Spronk, MD, PhD, Meta C.E. van der Woude, MD, PhD, Marcus J. Schultz, MD, PhD, David M.P. van Meenen, MD, PhD, Frederique Paulus, PhD, Lieuwe D.J. Bos, MD, PhD

Get full text